Patent 7605148 was granted and assigned to Aurobindo Pharma on October, 2009 by the United States Patent and Trademark Office.
The present invention relates to stable aqueous oral formulation of bisphosphonic acid or its pharmaceutically acceptable salts. More particularly, the present invention relates to stable aqueous oral formulation of alendronate sodium. The present invention also relates to a process for the preparation of stable aqueous oral formulation of alendronate sodium.